Redox, a Madison, Wisconsin-based Health tech firm, has clinched USD33 million in Series C funding round for Scalable Healthcare Data Interoperability Platform. This round was led by Battery Ventures, along with participation from existing investors .406 Ventures, RRE Ventures, and Intermountain Ventures. The company’s software allows healthcare apps to securely share data with big electronic medical records systems.
Software developers, with Redox’s interoperability platform, allow easy access through an instinctive and standardized application programming interface (API). Its vendor-agnostic approach offers messages to be sent or received securely in any format associated with an organization’s Electronic Health Record (EHR). Redox’s technology powers a streamlined workflow for care providers, improving care delivery and the patient experience, where clinicians can utilize a range of targeted apps and technology to meet their requirements, rather than a one-size-fits-all approach. With Redox’ solution, healthcare providers can cut down their integration times by two-thirds from an average of 100 days to 30 days. As per the reports, more than 450 healthcare providers and hundreds of Cloud-enabled applications so far, utilize the Redox Interoperability Platform to easily exchange information with partners.
Redox Co-founder and CEO Luke Bonney said that Redox’s success is built on the success of our customers, the most innovative software solutions and healthcare organizations in the market today. Bonney further added that we have a saying at Redox: ‘We are all patients.’ This informs our perspective about what we do as we build the infrastructure our customers rely on every day. We’re grateful to be in a position to help solve one of healthcare’s thorniest challenges.